Medihive announced that it has received Ã7 million in a round of funding led by new investor ResMed Inc. on January 27, 2023. The transaction included participation from returning investor VentureWave Capital. ResMed Inc. will take seat on the board of the company following the deal.
The transaction raised at post money valuation of Ã62 million.